The PHARM Connect Congress - Congresul PHARM Connect - cel mai important eveniment de afaceri pentru industria farmaceutica si biotehnologica din Europa Centrala si de Est si regiunea CSI
linkedin
facebook
Twitter
Youtube
 
For the 9th time in March 2019  
Budapest, Hungary Logheaza-te la meeting scheduler demo CZE ENG HUN POL ROU
  1. PHARM Connect
  2. Programme
  3. Awards
  4. Video
  5. Stiri
vr

PHARM Connect

Congresul PHARM Connect

Congresul PHARM Connect este cel mai mare si mai important eveniment de afaceri pentru industria farmaceutica si biotehnologica din Europa Centrala si de Est si regiunea CSI, ce are loc in fiecare an in februarie, in Budapesta, Ungaria.

Inca de la lansarea in 2011, evenimentul a reunit peste 500 de participanti din cel putin 20 de tari din regiune si nu numai. Pe durata celor doua zile ale congresului, furnizori de top din industria farmaceutica si biotehnologica – acoperind o gama larga de solutii si servicii de la API si contracte de fabricatie la comanda la procesare, solutii biofarma, substante si preparate biofarmaceutice si biologice, sisteme de livrare a medicamentelor, camere curate, echipamente de laborator, sisteme de control si monitorizare, controlul calitatii, ambalare si etichetare, automatizare, inginerie tehnologica si intretinere, logistica, depozitare la temperaturi controlate, distributie si multe altele – au sansa de a intalni principalii factori de decizie din companiile vizate.

Exclusivitate

Operarea strict pe baza de invitatii ofera garantia participarii delegatilor la cel mai inalt nivel. Fiecare furnizor este selectat inainte de eveniment in functie de cerintele si nevoile specialistilor participanti din industria farmaceutica.

Perspective de actualitate ale pietei

Nivelul inalt al calitatii programului congresului este asigurat prin stransa colaborare cu importante asociatii de specialitate regionale si locale, parteneri mass-media europeni si globali si Comitetul Consultativ, ai carui membri sunt experti binecunoscuti de la companii de top din industria farmaceutica si biotehnologica. Programul acopera cele mai actuale subiecte si tendinte ale pietei in domeniul R&D, productie, inginerie, lant de aprovizionare si managementul calitatii.

Intalniri de afaceri prestabilite

Pe durata celor doua zile, furnizorii vor avea ocazia sa intalneasca importanti factori de decizie si experti din industrie, prin intermediul intalnirilor de afaceri fata-in-fata prestabilite si alte activitati de relationare, sistemul reprezentand o sansa unica pentru dezvoltarea unor relatii de afaceri semnificative si valoroase.

Congresul ofera, de asemenea, participantilor posibilitatea de a vizita, in cadrul excursiilor special organizate, centre importante de productie farmaceutica, toate activitatile putand fi prestabilite prin sistemul „Meeting Scheduler”.

Locatie

Afacerile de succes sunt intotdeauna realizate intr-o atmosfera excelenta; acesta este motivul pentru care organizam congresul la Corinthia Grand Hotel in centrul Budapestei.

Stiri

04/05/2018

PHARM Connect 2018 - Post Event Press Release

PHARM Connect 2018 - Post Event Press Release PHARM Connect has become well known for its effectiveness in connecting professionals within the pharmaceutical and biotechnology industry in the strategically important region of Central and Eastern Europe and beyond.

Read more

03/19/2018

Interview with Lek Pharmaceuticals d.d.

Interview with Lek Pharmaceuticals d.d. Interview with the Winner of the 4th CEE Pharmaceutical Manufacturing Excellence Award in the manufacturer category

Read more

Buletin informativ - Abonare

Va vom tine la curent cu ultimele noutati referitoare la congres, tematica si program.

Daca doriti sa primiti in mod regulat noutati cu privire la Congresul PHARM Connect, va rugam sa va abonati aici trimitandu-ne un e-mail cu subiectul „subscribe”.

Va multumim pentru interesul manifestat.

Daca nu doriti sa mai primiti buletinul nostru informativ, va puteti dezabona aici, trimitandu-ne un e-mail cu subiectul „unsubscribe”.

video

PHARM Connect Congress 2016 LIVE

TEG The Events Group

video

PHARM Connect 2015 LIVE

TEG The Events Group

video

PHARM Connect 2015

One-to-One interview with Terry Siggins, GE IP

Awards

 

Lek Pharmaceuticals d.d. and SoftGroup received the 4th CEE Pharmaceutical Manufacturing Excellence Award in 2018

 

TEG with the support of the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) handed out the 4th Central Eastern European Pharmaceutical Manufacturing Excellence Award in 2018 to honour, recognise and promote outstanding manufacturing excellence solutions in the rapidly growing region of CEE. The award was handed out at the award ceremony at the PHARM Connect Congress 2018 in Budapest.

 

The 4th Central Eastern European Pharmaceutical Manufacturing Excellence Award ceremony together with the cocktail reception was opened by Professor Stane Srčič, Department of Pharmaceutical Technology, Faculty of Pharmacy University of Ljubljana, who announced the winner and handed out the award to the Bulgarian company SoftGroup in the service provider category and to the Slovenian company Lek Pharmaceuticals d.d. in the manufacturer category, emphasising that these tried methods will encourage professionals to constantly raise standards and come up with outstanding manufacturing excellence solutions, to further contribute to the development of the CEE region.

Applications were evaluated by an independent jury, by their level of innovation, service, cost-effectiveness and quality. The projects had to be accomplished in any of the countries in the CEE region in one of the two categories: manufacturers firstly and service providers with a customer related project secondly.

 

award winners 2018

Left-right: Vasil Pavlov, Plant Manager, Tchaikapharm; Venelin Dimitrov, CEO, SoftGroup; Mateja Šikovec, PhD, Project Manager Expert, Sandoz Development Center Slovenia, Lek Pharmaceuticals d.d.; Petra Perhavec, Group Head Pharmaceutical Development, Sandoz Development Center Slovenia, Lek Pharmaceuticals d.d.; Professor Stane Srčič, Department of Pharmaceutical Technology, Faculty of Pharmacy , University of Ljubljana;  Professor Vladimir Kral, University of Chemistry and Technology, Charles University; Dr. Lajos Hegedüs, Representative of the Hungarian Pharmaceutical Manufacturing Association (MAGYOSZ); Professor Imre Klebovich, Department of Pharmaceutics, Semmelweis University

 

Apply for the 5th CEE Pharmaceutical Manufacturing Excellence Award!

If you think your solution is cutting-edge and should be recognised by the industry, apply now for the 5th CEE Pharmaceutical Manufacturing Excellence Award and put your business in the spotlight!

 

Application closes: 31st of January 2019. You may send us your application by e-mail.

For full details of the 5th CEE Pharmaceutical Manufacturing Excellence Award, please click here.

 

For further information on the application process, please contact:  

Katy Säurich Head of Operations & Production at TEG

Email: katys@tegevents.eu | Tel: + 36 1 219-5725

Programme

PHARM Connect Congress 2018 will bring you an overview of the Central Eastern European market and the main trends and impacts on the pharmaceutical manufacturing & biotechnology world.

For speaking opportunities please contact

Katy Säurich, Operations & Production Manager at TEG

Email: katys@tegevents.eu | Tel: + 36 1 219-57-25


 PHARM CONNECT 2018 CHAIRPERSONS

Biotech and R&D:

Dr. András Ballagi

Chief Technology Officer, Diagon

Industrial:

Prof. Dr. Romána Zelkó

Dean Faculty of Pharmacy, Semmelweis University

Technological:

Prof. Dr. Stane Srčič

Head of Pharmaceutical Technology Department, Faculty of Pharmacy, University of Ljubljana

Regulatory:

Assoc. Prof. Dr. Ildikó Csóka

Director of the Institute of Pharmaceutical Technology and Regulatory Affairs

Faculty of Pharmacy, University of Szeged

 PHARM CONNECT 2018 SPEAKERS

 

Opening Keynote Presentation:

Biosimilars: Opportunities and Challenges for Pharmaceutical Industry. Pegfilgrastim Case Study

• Biologics, biosimilars, generics – facts and definitions

• Biosimilar market trends

• Pegfilgrastim case study: focus on clinical development and Phase III study considerations

Anna Aillerie, Head of Commercial Operations, Biotechnology Business Unit, Gedeon Richter

András Illés, Deputy Head of Clinical Development of Biologics, Gedeon Richter

Presentation:

Enabling smooth product life cycling – process characterization on sound data science and QbD tools  

Process characterization is a central tool in process validation from step 1 to 3 in the product life cycle. We need:

• Advanced statistics to be deployed to define NORS and PARs

• Models for experimental design, scale down models qualification and real-time predictive control

 

Univ. Prof. Dr. Christoph Herwig, Head of Research Division Biochemical Engineering, Institute of Chemical Environmental and Biological Engineering, Vienna University of Technology

Case Study Presentation:

Making it fit: The challenges of transferring new products into a running facility

• Key considerations of balancing project speed with manufacturing continuity

• An overview of the main risks of infrastructure modifications around (and inside) a running GMP unit

• Our key lessons learned and how we are executing further transfers effectively

• Interesting challenge - Transferring similar technologies

 

Judit Sallai, Technology Transfer Project Leader, GSK Biologicals Kft.

Christopher Hunley,Site Head and Managing Director, GSK Biologicals Kft. 

Case Study Presentation:

Implementing Single-use Continuous Bioprocessing: A case study on large-scale continuous mAb purification

• Process intensification through continuous bioprocessing

• Case study on large-scale continuous mAb purification

• Regulatory aspects of continuous bioprocessing

 

Britta Badertscher, MSc, Technical Specialist SLS, Pall International SARL

Presentation:

Three Dimensional Printing (3DP) technology in Pharmaceutical Manufacturing

• Technology description

• 3DP techniques & examples

• Spritam – first 3D printed drug product

• Advantages and challenges

 

Marek Cichocki, Head of Operational R&D, Polpharma

Case Study Presentation:

Quality by Design (QbD) Approach in Formulation Development

• FDA’s Initiative on Quality by Design (QbD)

• Introduction of QbD and its role in improvement of Quality

• The current Vs QbD approach of formulation development

• Five-step QbD methodology, key aspects and tools of QbD and Formulation by Design (FbD)

 

Dr. Devendra Ridhurkar, Senior Scientist (Special Formulations), Egis Pharmaceuticals

Case Study Presentation:

Orally Disintegrating Tablets and Films:

A Modern Innovative Drug Delivery System

 

Prof. Vladimír Král, Group Leader & Professor of Medicinal Chemistry, University of Chemistry and Technology, Prague & Medical School Charles University, BIOCEV Institute

Case Study Presentation:

Optimization of lyophilization process for the parenteral product

• Using PAT tools at the production scale

• Production scale up of the parenteral product

• Development of new lyo cycle in order to reduce total production cost (TPC) and increase production capacity

 

Dr. Aljoša Maglica, Product Steward Senior, Lek Pharmaceuticals d.d. / Novartis

Case Study Presentation:

Continuous manufacturing into the context of product development

• Critical factors to be considered and assessed upfront

• Early vs. late phase, in continuous product development

• Building the team and the technical confidence

 

Massimo Bresciani, Executive Director Scientific Operations & Board Member

Research Centre for Pharmaceutical Engineering (RCPE)

Case Study Presentation:

Xellia Central Laboratory Services case study

• Xellia history, present and future in a nutshell

• Central Laboratory Services concept and what is behind

• How to select, attract and integrate new colleagues considering the current challenging labor market

 

Eva Farkas, Quality Director, Head of Centralized Laboratory Services, Xellia

Case Study Presentation:

How to manage process deviations and showcase your data

A Laboratory case study

• Increase employees awareness around the concept „total cost of deviations“, as human errors are very often the main culprit

• Reduce process deviations from a daily to a monthly event, so that you can invest your time working on effective preventive actions rather than fire-fighting

• Present your data in the right way after all the hard work done: how to use the concepts of “Defect-free“ & 6-Sigma analysis

 

Eugenio Filippi, Associate Director Plasma Logistics & Analytics Europe, Shire

  PANEL DISCUSSION 

 How to handle impurities in general?

 • The improving analytical methods are able to show even the trace of impurities

 • Where is the limit of the increasing purity requirements?

 • How to satisfy regulatory requirements?

 • New guidelines for Elemental Impurities - Implementation best practice examples

Dr. Devendra Ridhurkar

Senior Scientist (special formulations), Egis Pharmaceuticals

Lenka Francišković

Head of Processes and Products Quality, Belupo Pharmaceuticals

Dr. Katalin Ganzler

Head of the Analytical Division, Formulation R&D delivery, Gedeon Richter  

 

 

 

 

 PROJECT PRESENTATIONS BY THE AWARD WINNERS
The CEE Pharmaceutical Manufacturing Excellence Award has been established to honour, recognise and promote outstanding manufacturing excellence solutions in the rapidly growing region of CEE. Manufacturers as well as solution providers were welcome to apply with their most innovative projects and methods implemented in the region. The winners have the opportunity to present their projects at PHARM Connect 2018.

Applications should be submitted by the 31st of January 2018 and will be assessed by our highly renowned jury.

For further information please click here.

 ADDITIONAL ACTIVITIES
 

PRE-EVENT PROGRAMME | 12th March 2018

Site visit to Meditop Pharmaceutical - The Winner of the 3rd CEE Pharmaceutical Manufacturing Excellence Award in 2017

 

Participants of PHARM Connect 2018 can learn more about the award winning innovation and visit the Meditop Pharmaceutical plant near Budapest. It is limited for 30 delegates only and available on a complimentary, first-come, first-served basis at 15:00 on 12th March.

Meditop Pharmaceutical Ltd. as a middle size company develops and manufactures its own products and offers services as a Contract Manufacturing Organisation to produce solid dosage forms in flexible manner and to provide support in development and manufacturing of pharmaceutical and nutraceutical products suffering with special sensitivity.

Meditop Pharmaceutical developed an innovative approach to improve film coating efficiency with developing and applying of a continuous film coater for which they received the 3rd CEE Pharmaceutical Manufacturing Excellence Award in 2017. With the innovation they:

• Successfully developed a method to coat soft tablets with high quality,

• Managed to coat heat sensitive actives without degradation,

• Saved considerable time and energy, and

• Obtained flexible and fast change-over and batch size change. 

 

TRANSFER: The bus will leave in front of the CORINTHIA Hotel at 14:00 on 12th March and will return after the visit at approximately 18:00.

POST-EVENT PROGRAMME | 14th March 2018

Site visit to the Research Centre for Natural Sciences at the Hungarian Academy of Science (MTA TTK)

 

The congress provides the opportunity to visit the Research Centre for Natural Sciences at the Hungarian Academy of Science (MTA TTK) in Budapest; this is limited for 60 delegates only and available on a complimentary, first-come, first-served basis at 17:00 on 14th March. The MTA Research Centre for Natural Sciences carries out multidisciplinary research in natural sciences. 

Priorities are given to the following disciplines:

• Materials- and environmental chemistry

• Cognitive neuroscience and psychology

The visit will start with a short, introductory presentation about the MTA TTK. Afterwards, the delegates will have the opportunity to choose a tour to the two research institutes:

Materials- and environmental chemistry

Research of discovery and experimental development in some key areas of materials- and environmental science, with special emphasis on chemical aspects thereof. Exploratory research in the field of nanoscale functional materials and application of the results in integrated nano/micro systems.

Cognitive neuroscience and psychology

Research of discovery and applications in experimental psychology, human-, developmental and comparative psychophysiology, social development psychology, social psychology and cultural psychology.

 

TRANSFER: The bus will leave in front of the CORINTHIA Hotel at 16:00 on 14th March and will return after the visit at approximately 20:00.


vr
Sponsors
vr
PALL BIOTECH
Meditop

Excursion Partner

MTA TTK

Excursion Partner

View further sponsors

vr
Lista Sponsori - Exemplu
vr

View further sponsors

vr
Asociatii partenere
vr

View more

vr
Parteneri Mass-Media
vr
Exclusive Hungarian Media Partner
MarketingPirula- PirulaTrend

View more

vr

Congresul PHARM Connect - cel mai important eveniment de afaceri pentru industria farmaceutica si biotehnologica din Europa Centrala si de Est si regiunea CSI

vr

map

vr
| Mai multe informatii | Contactati-ne | Inscrie-te acum
TheEventsGroup © 2012 | Date cu caracter personal | Termeni si conditii
Design: Nortyx Program: Nortyx Web and Recording studio, Stage technic